← Alle mensen

BP

Bilal Piperdi

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Vijfjaars OS van pembrolizumab versus docetaxel bij eerder behandeld NSCLC: KEYNOTE-010 definitief

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-10

Pembrolizumab plus ipilimumab of placebo bij PD-L1≥50% NSCLC: KEYNOTE-598 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juli 2021

KEYNOTE-021 cohort G langetermijn OS: pembrolizumab plus pemetrexed-carboplatine

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-01

Pembrolizumab plus chemotherapie bij gemetastaseerd plaveiselcel-oesofaguscarcinoom: KEYNOTE-590 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2020-10

QoL met carboplatine-paclitaxel/nab-pac met of zonder pembrolizumab bij NSCLC: KEYNOTE-407 analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2020

Pembrolizumab plus CC-486 versus pembrolizumab plus placebo bij NSCLC: fase II

European journal of cancer (Oxford, England : 1990) · 2019-02

Pembrolizumab plus chemotherapie bij plaveiselcel-NSCLC: KEYNOTE-407 fase III

The New England journal of medicine · 22 november 2018